Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

The Sorin Freedom SOLO stentless tissue valve: early outcomes after aortic valve replacement.

Altintas G, Diken AI, Hanedan O, Yurdakok O, Ozyalcin S, Kucuker SA, Ozatik MA.

Tex Heart Inst J. 2013;40(1):50-5.

2.

Short-term hemodynamic performance of the Sorin Freedom SOLO stentless valve.

Da Col U, Di Bella I, Bardelli G, Ramoni E, Affronti A, Vidili A, Ragni T.

J Heart Valve Dis. 2007 Sep;16(5):546-50.

PMID:
17944127
3.

Aortic valve replacement with new-generation stentless pericardial valves: short-term clinical and hemodynamic results.

Grubitzsch H, Linneweber J, Kossagk C, Sanli E, Beholz S, Konertz WF.

J Heart Valve Dis. 2005 Sep;14(5):623-9.

PMID:
16245501
4.

Early postoperative outcome and hemodynamic performance of the sorin pericarbon stentless aortic valve.

Bonacchi M, Giunti G, Prifti E, Rostagno C, Bini M, Frati G, Sani G.

J Heart Valve Dis. 2002 Sep;11(5):703-9.

PMID:
12358408
5.

[The Sorin pericardial bioprosthesis--a stentless aortic valve with very good hemodynamic performance].

Gegouskov VA, Eckstein FS, Kipfer B, Berdat PA, Immer FF, Schmidli J, Seiler C, Zobrist C, Carrel TP.

Swiss Surg. 2003;9(5):247-52. German.

PMID:
14601329
6.

Do differences in early hemodynamic performance of current generation biologic aortic valves predict outcomes 1 year following surgery?

Thalji NM, Suri RM, Michelena HI, Greason KL, Dearani JA, Daly RC, Joyce LD, Stulak JM, Burkhart HM, Li Z, Schaff HV.

J Thorac Cardiovasc Surg. 2015 Jan;149(1):163-73.e2. doi: 10.1016/j.jtcvs.2014.09.027. Epub 2014 Sep 18.

PMID:
25439772
7.

The Freedom SOLO valve for aortic valve replacement: clinical and hemodynamic results from a prospective multicenter trial.

Beholz S, Repossini A, Livi U, Schepens M, El Gabry M, Matschke K, Trivedi U, Eckel L, Dapunt O, Zamorano JL.

J Heart Valve Dis. 2010 Jan;19(1):115-23.

PMID:
20329497
8.

The Sorin freedom stentless pericardial valve: clinical and echocardiographic performance at 10 years.

Milano AD, Dodonov M, Celiento M, Pizzuti M, Golia G, Faggian G, Bortolotti U, Mazzucco A.

Int J Artif Organs. 2012 Jul;35(7):481-8. doi: 10.5301/ijao.5000103.

PMID:
22661113
9.

Clinical and echocardiographic outcomes after implantation of the Trifecta aortic bioprosthesis: an initial single-centre experience.

Dell'Aquila AM, Schlarb D, Schneider SR, Sindermann JR, Hoffmeier A, Kaleschke G, Martens S, Rukosujew A.

Interact Cardiovasc Thorac Surg. 2013 Feb;16(2):112-5. doi: 10.1093/icvts/ivs460. Epub 2012 Nov 15.

10.

Left ventricular remodeling, hemodynamics and early clinical outcomes after aortic valve replacement with the Pericarbon Freedom stentless bioprosthesis: results from the Italian Prospective Multicenter Trial.

D'Onofrio A, Mazzucco A, Valfrè C, Zussa C, Martinelli L, Casabona R, Mazzola A, Gherli T, Badano LP, Fabbri A.

J Heart Valve Dis. 2011 Sep;20(5):531-9.

PMID:
22066357
11.

Hemodynamic performance of Trifecta: single-center experience of 400 patients.

Modi A, Budra M, Miskolczi S, Velissaris T, Kaarne M, Barlow CW, Livesey SA, Ohri SK, Tsang GM.

Asian Cardiovasc Thorac Ann. 2015 Feb;23(2):140-5. doi: 10.1177/0218492314533684. Epub 2014 May 13.

PMID:
24823382
12.

Left ventricular mass regression after sutureless implantation of the Perceval S aortic valve bioprosthesis: preliminary results.

Santarpino G, Pfeiffer S, Pollari F, Concistrè G, Vogt F, Fischlein T.

Interact Cardiovasc Thorac Surg. 2014 Jan;18(1):38-42. doi: 10.1093/icvts/ivt362. Epub 2013 Oct 8.

13.

Stented bioprosthetic valve hemodynamics: is the supra-annular implant better than the intra-annular?

Badano LP, Pavoni D, Musumeci S, Frassani R, Gianfagna P, Baldassi M, Tursi V, Mazzaro E, Zakja E, Fioretti PM, Livi U.

J Heart Valve Dis. 2006 Mar;15(2):238-46.

PMID:
16607907
14.

The St Jude Medical Trifecta aortic pericardial valve: results from a global, multicenter, prospective clinical study.

Bavaria JE, Desai ND, Cheung A, Petracek MR, Groh MA, Borger MA, Schaff HV.

J Thorac Cardiovasc Surg. 2014 Feb;147(2):590-7. doi: 10.1016/j.jtcvs.2012.12.087. Epub 2013 Mar 7.

PMID:
23477687
15.

Thrombocytopenia after aortic valve replacement with the Freedom Solo stentless bioprosthesis.

Yerebakan C, Kaminski A, Westphal B, Kundt G, Ugurlucan M, Steinhoff G, Liebold A.

Interact Cardiovasc Thorac Surg. 2008 Aug;7(4):616-20. doi: 10.1510/icvts.2007.169326. Epub 2008 May 27.

16.

A prospective, randomized comparison of 3 contemporary bioprosthetic aortic valves: should hemodynamic performance influence device selection?

Suri RM, Michelena HI, Burkhart HM, Greason KL, Daly RC, Dearani JA, Park SJ, Joyce LD, Stulak JM, Sundt TM 3rd, Li Z, Schaff HV.

J Thorac Cardiovasc Surg. 2012 Dec;144(6):1387-95, 1398; discussion 1395-7. doi: 10.1016/j.jtcvs.2012.07.105.

PMID:
23140964
17.

Short-term and mid-term results with the Sorin Freedom Solo aortic valve.

Ustunsoy H, Yasim A, Deniz H, Gokaslan G, Ozcaliskan O.

J Heart Valve Dis. 2013 Mar;22(2):215-21.

PMID:
23798211
18.

Clinical and haemodynamic outcomes in 804 patients receiving the Freedom SOLO stentless aortic valve: results from an international prospective multicentre study.

Grubitzsch H, Wang S, Matschke K, Glauber M, Heimansohn D, Tan E, Francois K, Thalmann M.

Eur J Cardiothorac Surg. 2015 Mar;47(3):e97-104. doi: 10.1093/ejcts/ezu471. Epub 2014 Dec 13.

PMID:
25501554
19.

European multicenter study with the Soprano valve for aortic valve replacement: one-year clinical experience and hemodynamic data.

Fischlein T, Otero-Coto E, Werkkala K, Passerone G, Marinelli G, Tarkka MR, Feindt P, Perez de Isla L, Zamorano JL.

J Heart Valve Dis. 2011 Nov;20(6):695-703.

PMID:
22655501
20.

Aortic valve replacement with the Sorin Pericarbon Freedom stentless valve: five-year follow up.

Nyawo B, Graham R, Hunter S.

J Heart Valve Dis. 2007 Jan;16(1):42-8.

PMID:
17315382
Items per page

Supplemental Content

Write to the Help Desk